SPOTLIGHT -
Paclitaxel as First-Line Treatment for Metastatic Breast Cancer
When administered as a single agent in pretreated patients with advanced breast cancer, paclitaxel (Taxol) exhibits remarkable antitumor activity. This trial was undertaken to compare paclitaxel with standard
